about
Tissue depletion of taurine accelerates skeletal muscle senescence and leads to early death in mice.Direct label-free measurement of the distribution of small molecular weight compound inside thick biological tissue using coherent Raman microspectroscopy.Protein and amino acid supplementation in older humans.Neuroprotective Mechanisms of Taurine against Ischemic Stroke.Neurodevelopment in children with intrauterine growth restriction: adverse effects and interventions.Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases.Effect of taurine on chronic and acute liver injury: Focus on blood and brain ammoniaNMR Metabolomics for Stem Cell type discrimination.Rapid changes in Atlantic grey seal milk from birth to weaning - immune factors and indicators of metabolic strain.Neuroprotective Functions Through Inhibition of ER Stress by Taurine or Taurine Combination Treatments in a Rat Stroke Model.Kinetic characterization of the human O-phosphoethanolamine phospho-lyase reveals unconventional features of this specialized pyridoxal phosphate-dependent lyase.Reduced plasma taurine level in Parkinson's disease: association with motor severity and levodopa treatment.Evaluation of sample preparation and chromatographic separation for the parallel determination of taurine and edaravone in rat tissues using HILIC-MS/MS.Protective effects of taurine in traumatic brain injury via mitochondria and cerebral blood flow.Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson's disease.Change in plasma levels of amino acid neurotransmitters and its correlation with clinical heterogeneity in early Parkinson's disease patients.Therapeutic effect of taurine against aluminum-induced impairment on learning, memory and brain neurotransmitters in rats.Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.Taurine supplementation abates cirrhosis-associated locomotor dysfunctionConstruction of a high-density genetic map and fine QTL mapping for growth and nutritional traits of Crassostrea gigas
P2860
Q34207406-D13F1EB0-2757-49A9-8C4C-763C3D527959Q36044026-92548EA7-7825-4C88-A4F5-2E4B6B03E239Q38096904-6ECE919B-FBEF-45C8-910F-71C709B8B522Q38222884-33D9B8EE-BE17-4A78-924C-2F320D5BAAD8Q38372962-88D8BE0C-0C06-40C0-B398-5ACE438DE566Q38635692-A93075FB-367C-412B-BFDD-136AE0F852B5Q41679488-F31E93E4-5955-4A23-8671-5119AA94E276Q45845978-E3F2DA0D-DAD4-4D6A-8F72-28C3B017ED87Q46255061-FA4677F7-CC79-4F06-9E64-7ECFC3F08D1AQ46315171-E0D3DCD1-008C-44CE-A754-119F0DB25E07Q46823953-06B4A9D0-69FA-47A9-AC88-0CCB0EBCB266Q47970736-D7766C0A-6F42-46C6-A80B-558FC03AD8F3Q48239519-C9191777-83B4-4CD0-8345-61E0F715CD73Q48759735-0DBB15AF-EACB-41D7-A39F-A2C250E1BD2AQ50241117-0311E5B7-C528-444F-A235-7957AF2736BDQ50249498-2E110CA0-04EE-429F-869F-CC9A0CB775C7Q50667403-FAF5EDAF-B674-4FF8-856B-B4743A06022BQ52641738-E565420F-630C-4E98-8057-63084F922D14Q57118027-2D85CB18-667C-4E16-BEB5-7320248DB861Q58720978-8C912094-E837-46C1-98DB-DB182DA7DC83
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Taurine and central nervous system disorders.
@en
type
label
Taurine and central nervous system disorders.
@en
prefLabel
Taurine and central nervous system disorders.
@en
P2093
P2860
P1433
P1476
Taurine and central nervous system disorders.
@en
P2093
Chunliu Pan
Howard Prentice
Janet Menzie
Jang-Yen Wu
P2860
P2888
P356
10.1007/S00726-012-1382-Z
P577
2012-08-19T00:00:00Z